REVLIMID*21CPS 25MG ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
16Crow-Fukase syndrome1

16. Crow-Fukase syndrome


Clinical trials : 13Drugs : 14 - (DrugBank : 7) / Drug target genes : 4 - Drug target pathways : 75 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries